NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be paid a dividend of $0.22 per share on Wednesday, April 1st. This represents a $0.88 annualized dividend and a dividend yield of 0.94%. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has approved a share repurchase plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 6.1% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a return on equity of 22.99% and a net margin of 13.80%. Baxter International's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.64 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Baxter International.

17 Wall Street analysts have issued 1-year price targets for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $94.00 in the next twelve months. This suggests a possible upside of 0.9% from the stock's current price. View Analyst Price Targets for Baxter International.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News coverage about BAX stock has been trending somewhat negative this week, InfoTrie reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a news impact score of -1.4 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Baxter International.

Baxter International saw a increase in short interest in January. As of January 31st, there was short interest totalling 6,470,000 shares, an increase of 45.1% from the January 15th total of 4,460,000 shares. Based on an average trading volume of 3,060,000 shares, the short-interest ratio is currently 2.1 days. Approximately 1.3% of the shares of the stock are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Cisco Systems (CSCO), Johnson & Johnson (JNJ), BlackRock (BLK), Verizon Communications (VZ), Honeywell International (HON), AT&T (T), Pfizer (PFE), Alibaba Group (BABA) and Home Depot (HD).

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Wealth Quarterback LLC (14.07%), State Street Corp (4.68%), Third Point LLC (3.43%), FMR LLC (2.64%), Caisse DE Depot ET Placement DU Quebec (1.34%) and Capital International Investors (0.89%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bessemer Group Inc., Schroder Investment Management Group, Bank of New York Mellon Corp, AQR Capital Management LLC, Janus Henderson Group PLC, Los Angeles Capital Management & Equity Research Inc. and Argent Capital Management LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Capital International Investors, Bank of Montreal Can, Third Point LLC, Alyeska Investment Group L.P., New York State Common Retirement Fund, PGGM Investments and Stifel Financial Corp. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $93.16.

Baxter International has a market capitalization of $47.56 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]